Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

Autoimmune diseases with high tissue recovery often relapse and remit, while those with low recovery rarely remit.

Adipose-derived stem cells are promising for regenerative medicine due to their accessibility, versatility, and low risk of immune rejection.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Mycophenolate mofetil may improve lupus nephritis remission more than cyclophosphamide but with uncertain safety.

Oral isotretinoin does not cause milia in acne patients.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

CO2 laser-associated PDT effectively treated therapy-resistant folliculitis decalvans.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Long-term use of difluprednate eye drops in dogs can lead to hair loss and hormone imbalance.

Baricitinib helped most teenagers with severe hair loss regrow hair and had mild side effects.

PRP is a promising and safe treatment for early to moderate knee osteoarthritis but needs standardized protocols.

Dupilumab improved severe atopic dermatitis in a patient who didn't respond to other treatments.

Acupuncture may help with hair regrowth in alopecia areata, but more research is needed.

These new skin treatments are safer and more effective with minimal side effects.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

5-Alpha-Reductase inhibitors might help slow down hair loss in Frontal Fibrosing Alopecia but are not a primary treatment and need more research.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Acitretin is effective for severe skin conditions but has significant side effects and requires careful monitoring.

Semifluorinated alkanes are promising for delivering drugs in various medical applications.

A woman with lupus and antiphospholipid syndrome had bone damage, showing the need for careful treatment.

Early diagnosis and treatment of EGFR inhibitor-induced folliculitis decalvans can prevent permanent hair loss.

Ellagic acid can help treat skin issues, but its effectiveness is limited by poor absorption, so new delivery methods are being explored.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

The drug combination was safe and showed promise in treating advanced tumors.

Higher doses of glucocorticoids increase the risk of blood clots in asthma patients.